Onset of lichen planus during treatment with etanercept

American Journal of Clinical Dermatology

Volumn 11, Issue SUPPL. 1, 2010, Pages 55-56

  Musumeci, Maria Letizia ^a   Lacarrubba, Francesco ^a   Micali, Giuseppe ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE DERIVATIVE; BETAMETHASONE PROPIONATE; CORTICOSTEROID; ETANERCEPT; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CASE REPORT; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; HUMAN; HYPERKERATOSIS; LICHEN PLANUS; MALE; NAIL DYSTROPHY; PRIORITY JOURNAL; PSORIASIS VULGARIS; SKIN DEFECT; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 77954303356     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.2165/1153428-S0-000000000-00000     Document Type: Article

References (12)

1. Sobell JM, Kalb RE, Weinberg JM. Management of moderate to severe plaque psoriasis (part I) : clinical update on antitumor necrosis factor agents. J Drugs Dermatol 2009;8:147-54
2. Castelo-Soccio L, Van Voorhees AS. Long-term efficacy of biologics in dermatology. Dermatol Ther 2009;22:22-33
3. Jiménez-Puya R, Gómez-García F, Amorrich-Campos V, et al. Etanercept: efficacy and safety. J Eur Acad Dermatol Venereol 2009;23:402-5
4. Battistella M, Rivet J, Bachelez H, et al. Lichen planus associated with etanercept. Br J Dermatol 2008;158:188-90
5. Garcovich S, Manco S, Zampetti A, et al. Onset of lichen planopilaris during treatment with etanercept. Br J Dermatol 2008;158:1161-3
6. Scheinfeld N. A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab. J Dermatolog Treat 2004;15:280-94
7. De BandtM, Sibilia J, Le Loet X, et al. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey. Arthritis Res Ther 2005;7:545-51
8. Lee HH, Song IH, Friedrich M, et al. Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists. Br J Dermatol 2007;156:486-91
9. Soliotis F, Glover M, Jawad AS. Severe skin reaction after leflunomide and etanercept in a patient with rheumatoid arthritis. Ann Rheum Dis 2002;61:850-1;
10. comment in Ann Rheum Dis 2008;67:899-900
11. Vergara G, Silvestre JF, Betlloch I, et al. Cutaneous drug eruption to infliximab: report of 4 cases with an interface dermatitis pattern. Arch Dermatol 2002;138:1258-9
12. Richette P, Viguier M, Bachelez H, et al. Psoriasis induced by anti-tumour necrosis factor therapy: a class effect? J Rheumatol 2007;34:438-9